GlassScriptPhysician profile
Joseph D Ruffo
NPI 1891778882
$1,639.14
in general payments reported to CMS, 2019-2025
16 companies · $274 in 2025
The $274 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $553 · 2020: $199 · 2021: $74.79 · 2022: $194 · 2023: $168 · 2024: $176 · 2025: $274.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $619.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $618.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $324.29 | 2019-2025 | Renasys Touch |
| Paratek Pharmaceuticals, INC. | $195.80 | 2021-2025 | Nuzyra |
| Treace Medical Concepts, INC. | $176.43 | 2024 | |
| Wright Medical Technology, INC. | $168.62 | 2019 | |
| Bioventus LLC | $165.40 | 2021-2023 | |
| Medtronic Vascular, INC. | $133.28 | 2019 | |
| Baudax Bio INC. | $125.01 | 2020 | |
| Novo Nordisk INC | $104.83 | 2019 | |
| Djo, LLC | $69.51 | 2025 | Cmf |
| Melinta Therapeutics, LLC | $49.19 | 2019 | |
| Vanda Pharmaceuticals INC. | $32.11 | 2020 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $20.79 | 2022 | |
| Orthofix Medical, INC. | $20.78 | 2023 | Physio-Stim |
| Grt US Holding, INC. | $19.28 | 2021 | |
| Medtronic, INC. | $19.05 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $14.77 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Ruffo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.